The Breakthrough in Understanding 5-oxoETE
Scientists at the Sloan Kettering Cancer Center have solved a biological puzzle that has persisted for over 30 years concerning the molecule 5-oxoETE and its involvement in the immune response. Central to this discovery is the DHRS7 gene, which produces a crucial enzyme regulating inflammation and protecting cells. These findings could pave the way for innovative treatments targeting inflammatory diseases and cancer.
5-oxoETE functions as a distress signal when pathogens are detected in the body. Since 1992, researchers struggled to identify the human gene responsible for producing and breaking down the enzyme linked to this molecule. The DHRS7 gene performs this role in humans, although it lost functionality during evolution in mice. Interestingly, zebrafish possess an active 5-oxoETE receptor. Disabling either this receptor or the DHRS7 gene in zebrafish triggered colitis outbreaks without infection, highlighting its critical protective role.
The Significance of This Research
The study also revealed that the signaling pathway activated by 5-oxoETE stimulates NUDIX hydrolase enzymes, which safeguard healthy cells from harmful substances. Disruptions in this pathway have been observed in conditions such as asthma, inflammatory bowel diseases, and certain cancers. Additionally, physical damage to cell membranes causes the release of arachidonic acid, underscoring 5-oxoETE's importance in these biological processes. The DHRS7 gene enhances this signaling, enabling the body to detect threats and prevent self-inflicted tissue damage.
This breakthrough offers promising avenues for future research into therapies for inflammatory disorders and cancer. By defining the role of DHRS7 and 5-oxoETE in immune regulation, scientists are opening doors to more targeted and effective treatments that could improve the quality of life for patients suffering from chronic illnesses.